Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cholangiocarcinoma × Matrix Metalloproteinases × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sleep Initiation and Maintenance Disorders 1 Cholangiocarcinoma 1

Interventions

Gemcitabine 69 Cisplatin 41 Oxaliplatin 31 lenvatinib 22 durvalumab 21 Capecitabine 21 Fluorouracil 18 Leucovorin 13 pembrolizumab 10 apatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 7 Magnetic Resonance Spectroscopy 7 Liver Transplantation 7 Floxuridine 7 Drug Therapy 7 Cholangiopancreatography, Endoscopic Retrograde 7 tremelimumab 6 pemigatinib 6 Surgical Procedures, Operative 6 Photochemotherapy 6 Panitumumab 6 Irinotecan 6 Folfox protocol 6 130-nm albumin-bound paclitaxel 6 sintilimab 5 camrelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02893085 2016-12-28

ONCOBIL

CHU de Reims

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡